Chronic migraine, characterized by frequent headaches, presents substantial treatment challenges. Dr. Rebecca Burch's clinical review highlights the risks associated with medication overuse and presents significant advances in treatment approaches and understanding of progression risks.

The review emphasizes the potential of a calcitonin gene-related peptide receptor antagonist and behavioral interventions in reducing migraine days, while underscoring the importance of comprehensive treatment approaches to enhance the quality of life for individuals with chronic migraine.